We are live on
!
Find out more
KFC
Klingenstein Fields & Co Portfolio holdings
AUM
$2.86B
1-Year Est. Return
28.26%
This Fund
S&P 500
This Quarter
Est. Return
+3.16%
1 Year Est. Return
+28.26%
3 Year Est. Return
+93.38%
5 Year Est. Return
+106.8%
10 Year Est. Return
+364.29%
AUM
$2.6B
AUM Growth
+$48.1M
(+1.9%)
Cap. Flow
-$19.5M
Cap. Flow
% of AUM
-0.75%
Top 10 Holdings %
Top 10 Hldgs %
37.12%
Holding
232
New
10
Increased
45
Reduced
101
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$22.1M |
| 2 |
Schwab International Equity ETF
SCHF
|
+$14.7M |
| 3 |
IBM
IBM
|
+$9.86M |
| 4 |
Schwab U.S Small- Cap ETF
SCHA
|
+$9.81M |
| 5 |
Oracle
ORCL
|
+$9.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$16.5M |
| 2 |
PepsiCo
PEP
|
+$12.1M |
| 3 |
Gilead Sciences
GILD
|
+$9.61M |
| 4 |
COL
Rockwell Collins
COL
|
+$4.97M |
| 5 |
Procter & Gamble
PG
|
+$4.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.53% |
| 2 | Financials | 16.35% |
| 3 | Communication Services | 15.88% |
| 4 | Healthcare | 13.72% |
| 5 | Consumer Staples | 10.86% |
Similar funds
AHSSHC
YC
MSDF
SAI
LIP
DMIC
PFM
AIP
Klingenstein Fields & Co's Q3 2017 Portfolio in Review
As of Q3 2017, Klingenstein Fields & Co held 232 positions worth $2.6B, up 1.9% from $2.55B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Klingenstein Fields & Co's Q3 2017 filing shows 10 new, 45 increased, 101 reduced and 15 closed positions. Its largest new stake was Applied Materials: 11,560 shares worth $602K. The largest sale was Biogen, an estimated $16.5M.
By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
- Klingenstein Fields & Co's largest Q3 2017 buy was Applied Materials: 11,560 shares worth $602K.
- Klingenstein Fields & Co added most to Intel in Q3 2017, an estimated $22.1M increase.
- Klingenstein Fields & Co's biggest Q3 2017 reduction was PepsiCo, cutting an estimated $12.1M.
- Klingenstein Fields & Co fully exited Biogen in Q3 2017, selling an estimated $16.5M.
- Klingenstein Fields & Co's ten largest holdings make up 37% of its $2.6B portfolio in Q3 2017.
- Klingenstein Fields & Co opened 10 new positions and closed 15 in Q3 2017.
- Klingenstein Fields & Co's portfolio value rose 1.9% quarter-over-quarter to $2.6B.
Based on Klingenstein Fields & Co's 13F filing for Q3 2017, filed 1 Nov 2017.